Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-Analysis
Authors:
- 30 April 2025
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 138 (9) , 1238-1247.e4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular CarcinomaClinical Gastroenterology and Hepatology, 2024
- Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future CirrhosisClinical Gastroenterology and Hepatology, 2024
- Alcohol Intake Thresholds Among Individuals With Steatotic Liver DiseaseJAMA Network Open, 2023
- Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020Clinical Gastroenterology and Hepatology, 2023
- Statin Use for the Primary Prevention of Cardiovascular Disease in AdultsJAMA, 2022
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical SettingsEndocrine Practice, 2022
- Aspirin Use to Prevent Cardiovascular DiseaseJAMA, 2022
- Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018Clinical and Experimental Nephrology, 2018
- The Use of Liver Biopsy in Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease, 2018
- Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and OutcomesClinical Gastroenterology and Hepatology, 2015